Status:
COMPLETED
Exercise and Glycemic Control in Type 2 Diabetes
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Diabetes Mellitus, Type 2
Hyperglycemia
Eligibility:
MALE
40-65 years
Phase:
NA
Brief Summary
Hyperglycemia is an independent risk factor for the development of diabetic complications in type 2 diabetes. Exercise improves glycemic control, however, the role of exercise characteristics (e.g. in...
Eligibility Criteria
Inclusion
- Impaired glucose tolerant subjects
- BMI 25 - 35 kg/m2
- Impaired Glucose Tolerant (according to ADA guidelines)
Exclusion
- Cardiac disease (cardiac event in the last 5 years)
- Type 2 diabetes
- Use of orale blood glucose lowering medication or exogenous insulin
- HbA1c \>10%
- Insulin treated type 2 diabetes patients
- Inclusion Criteria:
- BMI 25 - 35 kg/m2
- Insulin therapy
- diagnosed with type 2 diabetes \>2 yr
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT00945165
Start Date
July 1 2009
End Date
June 1 2012
Last Update
October 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Centre
Maastricht, Limburg, Netherlands, 6200 MD